Beta 1-integrin-c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes

Nature Communications

Volumn 7, Issue , 2016, Pages

  Barrow McGee, Rachel ^a   Kishi, Naoki ^a   Joffre, Carine ^a,f   Ménard, Ludovic ^a,g   Hervieu, Alexia ^a,h   Bakhouche, Bakhouche A ^a   Noval, Alejandro J ^a   Mai, Anja ^b   Guzmán, Camilo ^b   Robert Masson, Luisa ^a,i   Iturrioz, Xavier ^c,j   Hulit, James ^a,k   Brennan, Caroline H ^d   Hart, Ian R ^a   Parker, Peter J ^c,e   Ivaska, Johanna ^b   Kermorgant, Stéphanie ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF TURKU   (Finland)

^c THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f CANCER RESEARCH CENTER OF TOULOUSE   (France)

^g ASTRAZENECA   (United Kingdom)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j PSL RESEARCH UNIVERSITY   (France)

^k ROYAL VETERINARY COLLEGE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY PROTEIN 5; BETA1 INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SCATTER FACTOR RECEPTOR; TUBULIN; SCATTER FACTOR;

ADHESION; CANCER; CELLS AND CELL COMPONENTS; GENE EXPRESSION; MEMBRANE; PLASMA; PROTEIN; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; AUTOPHAGY RELATED ENDOMEMBRANE; CANCER LOCALIZATION; CARCINOGENESIS; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; TUMOR INVASION; ANIMAL; CELL ADHESION; CELL LINE; CELL MOTION; DRUG EFFECT; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; AUTOPHAGY; CARCINOGENESIS; CELL ADHESION; CELL LINE; CELL MOVEMENT; FIBROBLASTS; GENE EXPRESSION REGULATION; HEPATOCYTE GROWTH FACTOR; HUMANS; INTEGRIN BETA1; MICE; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION;

EID: 84975760693     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11942     Document Type: Article

References (57)

1. Trusolino, L., Bertotti, A. & Comoglio, P. M. MET signalling: principles and functions in development, organ regeneration and cancer. Nat. Rev. Mol. Cell. Biol. 11, 834-848 (2010).
2. Gherardi, E., Birchmeier, W., Birchmeier, C. & Vande Woude, G. Targeting MET in cancer: rationale and progress. Nat. Rev. Cancer 12, 89-103 (2012).
3. Kermorgant, S., Zicha, D. & Parker, P. J. PKC controls HGF-dependent c-Met traffic, signalling and cell migration. EMBO J. 23, 3721-3734 (2004).
4. Kermorgant, S. & Parker, P. J. Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation. J. Cell Biol. 182, 855-863 (2008).
5. Kermorgant, S., Zicha, D. & Parker, P. J. Protein kinase C controls microtubulebased traffic but not proteasomal degradation of c-Met. J. Biol. Chem. 278, 28921-28929 (2003).
6. Joffre, C. et al. A direct role for Met endocytosis in tumorigenesis. Nat. Cell Biol. 13, 827-837 (2011).
7. Ivaska, J. & Heino, J. Cooperation between integrins and growth factor receptors in signaling and endocytosis. Annu. Rev. Cell Dev. Biol. 27, 291-320 (2011).
8. Desgrosellier, J. S. & Cheresh, D. A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 10, 9-22 (2010).
9. Soung, Y. H., Clifford, J. L. & Chung, J. Crosstalk between integrin and receptor tyrosine kinase signaling in breast carcinoma progression. BMB Rep. 43, 311-318 (2010).
10. De Franceschi, N., Hamidi, H., Alanko, J., Sahgal, P. & Ivaska, J. Integrin traffic - the update. J. Cell Sci. 128, 839-852 (2015).
11. Pellinen, T. & Ivaska, J. Integrin traffic. J. Cell Sci. 119, 3723-3731 (2006).
12. Margadant, C., Monsuur, H. N., Norman, J. C. & Sonnenberg, A. Mechanisms of integrin activation and trafficking. Curr. Opin. Cell Biol. 23, 607-614 (2011).
13. Wickstrom, S. A. & Fassler, R. Regulation of membrane traffic by integrin signaling. Trends Cell Biol. 21, 266-273 (2011).
14. Liu, Y. et al. Cleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway. Oncogene 28, 2756-2765 (2009).
15. Wang, R., Kobayashi, R. & Bishop, J. M. Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor. Proc. Natl Acad. Sci. USA 93, 8425-8430 (1996).
16. Mitra, A. K. et al. Ligand-independent activation of c-Met by fibronectin and alpha(5)beta(1)-integrin regulates ovarian cancer invasion and metastasis. Oncogene 30, 1566-1576 (2011).
17. King, S. J. et al. beta1 integrins regulate fibroblast chemotaxis through control of N-WASP stability. EMBO J. 30, 1705-1718 (2011).
18. Liang, C. C. & Chen, H. C. Sustained activation of extracellular signal-regulated kinase stimulated by hepatocyte growth factor leads to integrin alpha 2 expression that is involved in cell scattering. J. Biol. Chem. 276, 21146-21152 (2001).
19. Chiu, S. J., Jiang, S. T., Wang, Y. K. & Tang, M. J. Hepatocyte growth factor upregulates alpha2beta1 integrin in Madin-Darby canine kidney cells: implications in tubulogenesis. J. Biomed. Sci. 9, 261-272 (2002).
20. Trusolino, L. et al. Growth factor-dependent activation of alphavbeta3 integrin in normal epithelial cells: implications for tumor invasion. J. Cell Biol. 142, 1145-1156 (1998).
21. Roberts, M. S., Woods, A. J., Shaw, P. E. & Norman, J. C. ERK1 associates with alpha(v)beta 3 integrin and regulates cell spreading on vitronectin. J. Biol. Chem. 278, 1975-1985 (2003).
22. Fassler, R. & Meyer, M. Consequences of lack of beta 1 integrin gene expression in mice. Genes Dev. 9, 1896-1908 (1995).
23. Wennerberg, K. et al. Beta 1 integrin-dependent and -independent polymerization of fibronectin. J. Cell Biol. 132, 227-238 (1996).
24. Menard, L., Parker, P. J. & Kermorgant, S. Receptor tyrosine kinase c-Met controls the cytoskeleton from different endosomes via different pathways. Nat. Commun. 5, 3907 (2014).
25. Radtke, S. et al. ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell lines. J. Cell Sci. 126, 2381-2391 (2013).
26. Mai, A. et al. Distinct c-Met activation mechanisms induce cell rounding or invasion through pathways involving integrins, RhoA and HIP1. J. Cell Sci. 127, 1938-1952 (2014).
27. Barrow, R., Joffre, C., Menard, L. & Kermorgant, S. Measuring the role for Met endosomal signaling in tumorigenesis. Methods Enzymol. 535, 121-140 (2014).
28. Arjonen, A., Alanko, J., Veltel, S. & Ivaska, J. Distinct recycling of active and inactive beta1 integrins. Traffic 13, 610-625 (2012).
29. Rantala, J. K. et al. SHARPIN is an endogenous inhibitor of beta1-integrin activation. Nat. Cell Biol. 13, 1315-1324 (2011).
30. He, L., Ingram, A., Rybak, A. P. & Tang, D. Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells. J. Clin. Invest. 120, 2094-2108 (2010).
31. Pellinen, T. et al. Integrin trafficking regulated by Rab21 is necessary for cytokinesis. Dev. Cell 15, 371-385 (2008).
32. Pellinen, T. et al. Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of beta1-integrins. J. Cell Biol. 173, 767-780 (2006).
33. Wild, P., McEwan, D. G. & Dikic, I. The LC3 interactome at a glance. J. Cell Sci. 127, 3-9 (2014).
34. Sanjuan, M. A. et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 450, 1253-1257 (2007).
35. Florey, O., Gammoh, N., Kim, S. E., Jiang, X. & Overholtzer, M. V-ATPase and osmotic imbalances activate endolysosomal LC3 lipidation. Autophagy 11, 88-99 (2015).
36. Kim, S. E. & Overholtzer, M. Autophagy proteins regulate cell engulfment mechanisms that participate in cancer. Semin. Cancer Biol. 23, 329-336 (2013).
37. Martinez, J. et al. Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins. Nat. Cell Biol. 17, 893-906 (2015).
38. Shang, L. et al. Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK. Proc. Natl Acad. Sci. USA 108, 4788-4793 (2011).
39. Marino, G., Niso-Santano, M., Baehrecke, E. H. & Kroemer, G. Selfconsumption: the interplay of autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 15, 81-94 (2014).
40. Lamb, C. A., Yoshimori, T. & Tooze, S. A. The autophagosome: origins unknown, biogenesis complex. Nat. Rev. Mol. Cell Biol. 14, 759-774.
41. Martinez-Lopez, N., Athonvarangkul, D., Mishall, P., Sahu, S. & Singh, R. Autophagy proteins regulate ERK phosphorylation. Nat. Commun. 4, 2799 (2013).
42. Cowan, K. J., Law, D. A. & Phillips, D. R. Identification of shc as the primary protein binding to the tyrosine-phosphorylated beta 3 subunit of alpha IIbbeta 3 during outside-in integrin platelet signaling. J. Biol. Chem. 275, 36423-36429 (2000).
43. Caswell, P. T. et al. Rab-coupling protein coordinates recycling of alpha5beta1 integrin and EGFR1 to promote cell migration in 3D microenvironments. J. Cell Biol. 183, 143-155 (2008).
44. Trusolino, L., Bertotti, A. & Comoglio, P. M. A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth. Cell 107, 643-654 (2001).
45. Galluzzi, L. et al. Autophagy in malignant transformation and cancer progression. EMBO J. 34, 856-880 (2015).
46. Sandilands, E. et al. Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling. Nat. Cell Biol. 14, 51-60 (2012).
47. Tuloup-Minguez, V. et al. Autophagy modulates cell migration and beta1 integrin membrane recycling. Cell Cycle 12, 3317-3328 (2013).
48. Guadamillas, M. C., Cerezo, A. & Del Pozo, M. A. Overcoming anoikis-pathways to anchorage-independent growth in cancer. J. Cell Sci. 124, 3189-3197 (2011).
49. Yao, H. et al. Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation. Clin. Exp. Metastasis 27, 173-184 (2010).
50. Cianfrocca, M. E. et al. Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours. Br. J. Cancer 94, 1621-1626 (2006).
51. Stragies, R. et al. Design and synthesis of a new class of selective integrin alpha5beta1 antagonists. J. Med. Chem. 50, 3786-3794 (2007).
52. Farber, K. et al. An alpha5beta1 integrin inhibitor attenuates glioma growth. Mol. Cell Neurosci. 39, 579-585 (2008).
53. Ricart, A. D. et al. Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study. Clin. Cancer Res. 14, 7924-7929 (2008).
54. Jeffers, M. et al. Activating mutations for the met tyrosine kinase receptor in human cancer. Proc. Natl Acad. Sci. USA 94, 11445-11450 (1997).
55. Laukaitis, C. M., Webb, D. J., Donais, K. & Horwitz, A. F. Differential dynamics of alpha 5 integrin, paxillin, and alpha-actinin during formation and disassembly of adhesions in migrating cells. J. Cell Biol. 153, 1427-1440 (2001).
56. Bolte, S. & Cordelieres, F. P. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224, 213-232 (2006).
57. Costes, S. V. et al. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys. J. 86, 3993-4003 (2004).